Search NLS News

Affibody has announced that the first patients have been dosed in a clinical basket study of the PET imaging agent 68Ga-ABY-025 for non-invasive quantification of HER2-status in solid tumors. ABY-025 is based on an Affibody molecule that binds strongly to HER2 – a cell surface protein implicated in several forms of cancer. The high affinity […]

The two companies have entered into a definitive agreement for Genmab to acquire ProfoundBio in an all-cash transaction. Genmab will acquire ProfoundBio for USD 1.8 billion in cash, payable at closing. Genmab will acquire ProfoundBio for USD 1.8 billion in cash, payable at closing. “The proposed acquisition of ProfoundBio firmly aligns with our long-term strategy […]

The two companies have announced a collaboration to commercialize Oncopeptides’ drug Pepaxti in the Middle East and North Africa countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia, Morocco, Libya, Lebanon, and Iraq. Under the terms of this exclusive agreement, Vector will distribute Pepaxti to patients in the MENA region for the treatment […]

I’ve always been a great believer in seeing for yourself and for a number of reasons, 2024 seemed to be the moment to visit Arab Health. My previous visit a decade ago, working on renewable energy, had convinced me of the real commitment to finding solutions in that sector. I also knew that there has […]

The company has entered into a collaboration with a research group at University of Glasgow, UK, with the objective of performing an exploratory phase 2 study with rabeximod in patients with rheumatoid arthritis. ”We are extremely pleased to be able to announce this strategically important collaboration around rabeximod. It is an honor that Cyxone now […]

Taking the temperature of 2024 investment climate at Nordic American Healthcare Conference (NAHC), NYC. The recent years have been a bit of a roller-coaster for the life science industry’s confidence. Being at the epicenter of a global pandemic led us to collectively believe that the attention would last forever. Or at least longer than one […]

The two companies will develop digital patient monitoring for people with advanced renal cell carcinoma (RCC), using Elekta’s Kaiku Health solution, a digital platform for patient engagement and reported outcomes monitoring. Elekta, with support from MSD, will develop a digital module for patients, keeping them connected with their care team, and educating them about their […]

InDex Pharmaceuticals has announced that its CEO Jenny Sundqvist and its CFO & Deputy CEO Johan Giléus will leave the company per September 26, 2024. Jenny Sundqvist and Johan Giléus will both remain in their positions and at the company’s disposal until their last day of employment. Read more: InDex Pharmaceuticals discontinues phase III program […]

A unique feature of the HPP270 series probes is the ability to evaluate the sensors’ performance through its “Sensor Vitality” value. This value is like a health check for the sensor. The HPP270 series probes, which use PEROXCAP® sensor technology to measure vaporized hydrogen peroxide in bio-decontamination applications, do not have a specified calibration interval. […]

On Friday 9th of February, Oslo Science Park buzzed with life. A large crowd was present when the two ministers for health and trade announced the government’s fifteen point export strategy for the health industry. Although our two good neighbors, Sweden and Denmark, have had their life science strategies in place in years, this has […]